Previous Close | 3.7400 |
Open | 3.7700 |
Bid | 3.2500 x 100 |
Ask | 3.3200 x 400 |
Day's Range | 3.2600 - 3.7700 |
52 Week Range | 1.3700 - 9.8000 |
Volume | |
Avg. Volume | 724,503 |
Market Cap | 173.365M |
Beta (5Y Monthly) | 2.24 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Kodiak (KOD) reports better-than-expected first-quarter 2024 results and provides updates regarding its pipeline development plans.
We can readily understand why investors are attracted to unprofitable companies. For example, although...
Kodiak (KOD) initiates a phase III study evaluating tarcocimab in diabetic retinopathy, which is expected to serve as the basis for a regulatory filing for three eye disease indications.